You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cabozantinib

Showing 51 - 75 of 128
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Cabozantinib
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Old Age; Debility, Renal Carcinoma Metastatic Trial in Spain (Cabozantinib)

Recruiting
  • Old Age; Debility
  • Renal Carcinoma Metastatic
  • Cabozantinib
  • Ciudad Real, Spain
  • +9 more
Feb 8, 2022

Urothelial Carcinoma, Urethral Tumors, Urinary Bladder Tumors Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Urothelial Carcinoma
  • +3 more
  • Cabozantinib
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 16, 2021

Advanced Metastatic Melanoma Trial in Iowa City (Cabozantinib, Pembrolizumab)

Recruiting
  • Advanced Metastatic Melanoma
  • Iowa City, Iowa
    University of Iowa Hospitals and Clinics
Sep 13, 2021

Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

Not yet recruiting
  • Medullary Thyroid Cancer
  • Cordoba, Spain
  • +1 more
Jan 11, 2023

Kidney Cancer, Renal Cell Carcinoma Trial in New Brunswick, New York, Cleveland (Cabozantinib, Nivolumab, Cytoreductive

Recruiting
  • Kidney Cancer
  • Renal Cell Carcinoma
  • Cabozantinib
  • +2 more
  • New Brunswick, New Jersey
  • +2 more
Mar 22, 2022

Solid Tumor Trial in San Diego (Cabozantinib, 13-cis-retinoic acid)

Recruiting
  • Solid Tumor
  • Cabozantinib
  • 13-cis-retinoic acid
  • San Diego, California
    Rady Children's Hospital - San Diego
Oct 6, 2021

Colorectal Cancer, Colorectal Carcinoma, Metastatic Cancer Trial in Orange (Cabozantinib, TAS-102)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center, University of Californi
Sep 30, 2021

Colorectal Adenocarcinoma, Colon Cancer, Colon Adenocarcinoma Trial in United States (Cabozantinib, Nivolumab)

Recruiting
  • Colorectal Adenocarcinoma
  • +6 more
  • Aurora, Colorado
  • +4 more
Nov 19, 2021

Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,

Recruiting
  • Relapsed Ewing Sarcoma
  • +3 more
  • Cabozantinib
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 27, 2021

Differentiated Thyroid Cancer (DTC), Poorly Differentiated Thyroid Cancer Trial in Philadelphia (Cabozantinib)

Active, not recruiting
  • Differentiated Thyroid Cancer (DTC)
  • Poorly Differentiated Thyroid Cancer
  • Cabozantinib
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Oct 7, 2021

Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Unclassified Renal Cell Carcinoma, Papillary Renal Cell Carcinoma

Recruiting
  • Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
Feb 2, 2022

Metastatic Well Differentiated Neuroendocrine Tumor, Neuroendocrine Tumors Trial in Milano (Cabozantinib, Lanreotide)

Recruiting
  • Metastatic Well Differentiated Neuroendocrine Neoplasm
  • Neuroendocrine Tumors
  • Milano, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Sep 3, 2021

Locally Advanced Hepatocellular Carcinoma Trial in Baltimore (Cabozantinib, Nivolumab)

Active, not recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center
Aug 18, 2021

Urothelial Carcinoma Trial in Mainz (Cabozantinib)

Terminated
  • Urothelial Carcinoma
  • Cabozantinib
  • Mainz, Germany
    Department of Urology of the University Medical Center Mainz
Aug 24, 2021

Neuroendocrine Tumors,Gastroenteropancreatic Trial in Taipei (Cabozantinib, Lanreotide)

Not yet recruiting
  • Neuroendocrine Tumors,Gastroenteropancreatic
  • Taipei, Taiwan
    National Taiwan University Hospital
Sep 9, 2021

Solid Tumors With HRAS Alterations, Non Small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC) Trial (KO-2806, Cabozantinib)

Not yet recruiting
  • Solid Tumors With HRAS Alterations
  • +4 more
  • (no location specified)
Aug 30, 2023

Renal Cell Carcinoma, Papillary Renal Cell Carcinoma Type 1, Papillary Renal Cell Carcinoma Type 2 Trial in Australia

Recruiting
  • Renal Cell Carcinoma
  • +5 more
  • Cabozantinib
  • Albury, New South Wales, Australia
  • +10 more
Feb 14, 2022

Collecting Duct Carcinoma (Kidney) Trial in Milan (cabozantinib)

Completed
  • Collecting Duct Carcinoma (Kidney)
  • cabozantinib
  • Milan, Italy
    Giuseppe Procopio
May 7, 2021

Differentiated Thyroid Gland Carcinoma, Malignant Adrenal Gland Pheochromocytoma, Malignant Paraganglioma Trial in Houston

Active, not recruiting
  • Differentiated Thyroid Gland Carcinoma
  • +3 more
  • Computed Tomography
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 17, 2022

Hepatocellular Carcinoma, Recurrent Cancer, Liver Transplant Trial in Toronto (Cabozantinib)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Cabozantinib
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2021

Locally Advanced or Metastatic Renal Cell Carcinoma Trial in Worldwide (Cabozantinib)

Active, not recruiting
  • Locally Advanced or Metastatic Renal Cell Carcinoma
  • Cabozantinib
  • Salzburg, Austria
  • +39 more
Jan 18, 2023

Breast Cancer, Brain Tumor - Metastatic Trial in Boston (Cabozantinib, Trastuzumab)

Completed
Has Results
  • Breast Cancer
  • Brain Tumor - Metastatic
  • Boston, Massachusetts
  • +1 more
May 18, 2021

Advanced Clear Cell Renal Cell Carcinoma, Metastatic Clear Cell Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8 Trial

Recruiting
  • Advanced Clear Cell Renal Cell Carcinoma
  • +3 more
  • Cabozantinib
  • +2 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Dec 2, 2022

Salivary Gland Cancer Trial in Nijmegen (Cabozantinib)

Terminated
  • Salivary Gland Cancer
  • Cabozantinib
  • Nijmegen, Gelderland, Netherlands
    Radboudumc
Mar 11, 2021